Perelman School of Medicine: CAR Macrophages Go Beyond T Cells to Fight Solid Tumors
March 24, 2020
March 24, 2020
PHILADELPHIA, Pennsylvania, March 24 [TNSmedicalresearch] -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
- Penn researchers publish proof-of-concept to use alternative immune cells to target cancer
* * *
Chimeric antigen receptor (CAR) T cell therapy has been a game-changer for blood cancers but has faced challenges in targeting solid tumors. Now researchers from the Perelman School of M . . .
* * *
- Penn researchers publish proof-of-concept to use alternative immune cells to target cancer
* * *
Chimeric antigen receptor (CAR) T cell therapy has been a game-changer for blood cancers but has faced challenges in targeting solid tumors. Now researchers from the Perelman School of M . . .